| Authors: |
Fifer S; CaPPRe: Community and Patient Preference Research, Sydney, NSW, Australia. simon.fifer@cappre.com.au., Esposito C; Nephrology, ICS Maugeri, University of Pavia, Pavia, Italy., Correa-Rotter R; Department of Nephrology and Mineral Metabolism, National Medical Science and Nutrition Institute Salvador Zubiran, Mexico City, Mexico., Wu MS; College of Medicine, Taipei Medical University, Taipei, Taiwan., Reichel H; Nephrological Center, Villingen-Schwenningen, Germany., Elsayed HM; Department of Internal Medicine and Nephrology, Faculty of Ain Shams University, Cairo, Egypt., Sanchez JJG; Health Economic and Payer Evidence, AstraZeneca, Barcelona, Spain., Pentakota S; Global Medical Affairs, Biopharmaceutical Medical, AstraZeneca, Cambridge, UK., Kularatne T; CaPPRe: Community and Patient Preference Research, Sydney, NSW, Australia., Hull R; Renal and Transplantation Unit, St George's University Hospital NHS Foundation Trust, London, UK., Chadban S; Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia. |
